share_log

JMP Securities Reiterates Market Outperform on Arbutus Biopharma, Maintains $4 Price Target

Moomoo 24/7 ·  Apr 4 08:49

JMP Securities analyst Roy Buchanan reiterates Arbutus Biopharma (NASDAQ:ABUS) with a Market Outperform and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment